BACKGROUND: Both alcohol consumption and obesity have been linked with breast cancer morbidity and mortality. An inverse association between alcohol intake and obesity suggests possible confounding between these variables (and perhaps other factors) with breast cancer outcomes. METHODS: Alcohol intake (beer, wine, spirits, and total) was examined in 3,088 women previously diagnosed and treated for breast cancer within an intervention trial that targeted vegetables, fiber, and fat but not alcohol or weight loss. Factors associated with baseline alcohol intake were included in Cox proportional hazards models for recurrence and mortality. RESULTS: Alcohol intake was significantly associated with higher education and physical activity levels. Neither light alcohol intake nor obesity was significantly associated with breast cancer recurrence, but moderate alcohol intake >300 g/mo was protective against all-cause mortality (hazard ratio, 0.69; 95% confidence intervals, 0.49-0.97) in a proportional hazards model adjusted for obesity. Obese women were 61% more likely to be nondrinkers than drinkers, and 76% more likely to be light drinkers than moderate/heavy drinkers. In nonobese women, alcohol intake >10 g/mo was associated with lower risk of all-cause mortality (hazard ratio, 0.68; 95% confidence intervals, 0.51-0.91). CONCLUSION: Light alcohol intake, regardless of body weight, did not increase the risk of breast cancer recurrence or all-cause mortality in this cohort of middle-aged women previously diagnosed with breast cancer. Alcohol intake was associated with other favorable prognostic indicators, which may explain its apparent protective effect in nonobese women.
BACKGROUND: Both alcohol consumption and obesity have been linked with breast cancer morbidity and mortality. An inverse association between alcohol intake and obesity suggests possible confounding between these variables (and perhaps other factors) with breast cancer outcomes. METHODS:Alcohol intake (beer, wine, spirits, and total) was examined in 3,088 women previously diagnosed and treated for breast cancer within an intervention trial that targeted vegetables, fiber, and fat but not alcohol or weight loss. Factors associated with baseline alcohol intake were included in Cox proportional hazards models for recurrence and mortality. RESULTS:Alcohol intake was significantly associated with higher education and physical activity levels. Neither light alcohol intake nor obesity was significantly associated with breast cancer recurrence, but moderate alcohol intake >300 g/mo was protective against all-cause mortality (hazard ratio, 0.69; 95% confidence intervals, 0.49-0.97) in a proportional hazards model adjusted for obesity. Obesewomen were 61% more likely to be nondrinkers than drinkers, and 76% more likely to be light drinkers than moderate/heavy drinkers. In nonobese women, alcohol intake >10 g/mo was associated with lower risk of all-cause mortality (hazard ratio, 0.68; 95% confidence intervals, 0.51-0.91). CONCLUSION: Light alcohol intake, regardless of body weight, did not increase the risk of breast cancer recurrence or all-cause mortality in this cohort of middle-aged women previously diagnosed with breast cancer. Alcohol intake was associated with other favorable prognostic indicators, which may explain its apparent protective effect in nonobese women.
Authors: J F Dorgan; D J Baer; P S Albert; J T Judd; E D Brown; D K Corle; W S Campbell; T J Hartman; A A Tejpar; B A Clevidence; C A Giffen; D W Chandler; F Z Stanczyk; P R Taylor Journal: J Natl Cancer Inst Date: 2001-05-02 Impact factor: 13.506
Authors: Christopher I Li; Janet R Daling; Peggy L Porter; Mei-Tzu C Tang; Kathleen E Malone Journal: J Clin Oncol Date: 2009-09-08 Impact factor: 44.544
Authors: John P Pierce; Susan Faerber; Fred A Wright; Cheryl L Rock; Vicky Newman; Shirley W Flatt; Sheila Kealey; Vicky E Jones; Bette J Caan; Ellen B Gold; Mary Haan; Kathryn A Hollenbach; Lovell Jones; James R Marshall; Cheryl Ritenbaugh; Marcia L Stefanick; Cynthia Thomson; Linda Wasserman; Loki Natarajan; Ronald G Thomas; Elizabeth A Gilpin Journal: Control Clin Trials Date: 2002-12
Authors: H Irene Su; Laura Y Sue; Shirley W Flatt; Loki Natarajan; Ruth E Patterson; John P Pierce Journal: J Womens Health (Larchmt) Date: 2013-10-10 Impact factor: 2.681
Authors: Vicki Hart McLaughlin; Amy Trentham-Dietz; John M Hampton; Polly A Newcomb; Brian L Sprague Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-01-08 Impact factor: 4.254
Authors: Martha L Slattery; Abbie Lundgreen; Esther M John; Gabriela Torres-Mejia; Lisa Hines; Anna R Giuliano; Kathy B Baumgartner; Mariana C Stern; Roger K Wolff Journal: Nutr Cancer Date: 2015-01-28 Impact factor: 2.900
Authors: Christopher Thomas Veal; Vicki Hart; Susan G Lakoski; John M Hampton; Ronald E Gangnon; Polly A Newcomb; Stephen T Higgins; Amy Trentham-Dietz; Brian L Sprague Journal: J Cancer Surviv Date: 2017-01-05 Impact factor: 4.442
Authors: Marilyn L Kwan; Lawrence H Kushi; Erin Weltzien; Emily K Tam; Adrienne Castillo; Carol Sweeney; Bette J Caan Journal: J Clin Oncol Date: 2010-08-30 Impact factor: 44.544
Authors: Marilyn L Kwan; Wendy Y Chen; Shirley W Flatt; Erin K Weltzien; Sarah J Nechuta; Elizabeth M Poole; Michelle D Holmes; Ruth E Patterson; Xiao Ou Shu; John P Pierce; Bette J Caan Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-11-13 Impact factor: 4.254
Authors: Polly A Newcomb; Ellen Kampman; Amy Trentham-Dietz; Kathleen M Egan; Linda J Titus; John A Baron; John M Hampton; Michael N Passarelli; Walter C Willett Journal: J Clin Oncol Date: 2013-04-08 Impact factor: 44.544
Authors: Beth A Vorderstrasse; Tao Wang; Annette K Myers; Katherine L Wyrick; Gary G Meadows Journal: Breast Cancer Res Treat Date: 2012-11-02 Impact factor: 4.872